Bana Antonios, Oyepeju Folashade Abioye, Grace Gorecki, Shifeng S. Mao. "Real-world data from the TriNetX database comparing abiraterone versus darolutamide in hormone-sensitive prostate cancer.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.e17092